Literature DB >> 2939711

Impaired immunoglobulin synthesis in multiple myeloma: a B-cell dysfunction.

A Carter, I Silvian, I Tatarsky, G Spira.   

Abstract

Peripheral blood samples collected from normal individuals and patients with benign monoclonal gammopathy and multiple myeloma were separated and assayed for their T- and B-cell subpopulations as well as immunoglobulin (IgG, IgM) synthesis in vitro. To rule out any functional or quantitative alterations related to therapy, only newly diagnosed multiple myeloma patients and subjects with benign monoclonal gammopathy were included in our study. Multiple myeloma patients were further subdivided into two groups. Group A consisted of patients with low and intermediate tumor burdens, while group B included patients with high tumor mass. B- and T-cell subset analysis revealed an abnormal ratio between B/T and OKT4+/OKT8+ lymphocytes compared to healthy controls. These alterations were especially prominent in group B multiple myeloma. Immunoglobulin synthesis was studied in pokeweed-mitogen-stimulated lymphocyte cultures. The results indicate that the failure to synthesize and secrete immunoglobulin resides within the B-cell lineage and is probably due to a functional B-cell defect. T-cell immunoregulatory functions seem to be unaffected in both multiple myleoma and benign monoclonal gammopathy patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2939711     DOI: 10.1002/ajh.2830220205

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  5 in total

Review 1.  Mechanisms of polyclonal hypogammaglobulinaemia in multiple myeloma (MM).

Authors:  M C Kyrtsonis; A Mouzaki; A Maniatis
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

2.  Antigen stimulated IgM secretion by circulating B lymphocytes in patients with benign and malignant IgG gammopathy. Relationship to stage of disease.

Authors:  S Pollack; R Katz; I Tatarsky; A Carter
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

3.  Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut.

Authors:  Kyoung-Mu Lee; Dalsu Baris; Yawei Zhang; H Dean Hosgood; Idan Menashe; Meredith Yeager; Shelia Hoar Zahm; Sophia S Wang; Mark P Purdue; Stephen Chanock; Tongzhang Zheng; Nathaniel Rothman; Qing Lan
Journal:  Am J Hematol       Date:  2010-08       Impact factor: 10.047

4.  Autoregulatory circuits in myeloma. Tumor cell cytotoxicity mediated by soluble CD16.

Authors:  R G Hoover; C Lary; R Page; P Travis; R Owens; J Flick; J Kornbluth; B Barlogie
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

Review 5.  Myeloid-derived suppressor cells as therapeutic target in hematological malignancies.

Authors:  Kim De Veirman; Els Van Valckenborgh; Qods Lahmar; Xenia Geeraerts; Elke De Bruyne; Eline Menu; Ivan Van Riet; Karin Vanderkerken; Jo A Van Ginderachter
Journal:  Front Oncol       Date:  2014-12-08       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.